ReviewJournal of market access & health policy2017

A comparative review of Haute Autorité de Santé and National Institute for Health and Care Excellence health technology assessments of Ikervis® to treat severe keratitis in adult patients with dry eye disease which has not improved despite treatment with tear substitutes.

Yasmina Iffet ErogluPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.